Stemden
PrivateLast Round
Seed
Jan 15, 2026
Total Funding Raised
$185,000
Company Overview
Stemden is a biotechnology company that develops oral tissue regeneration treatments using cell activation-based technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stemden Comparables
Compare Stemden with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HysensBio | 83% | |
| Mintech-Bio | 74% | |
| Toregem BioPharma | 74% | |
Stemden Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 15, 2026 | ||||
| Grant | Oct 30, 2024 | ||||
| Seed | Jun 1, 2022 |
Stemden Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startup SG | Grant |
| TIPS (Tech Incubator Program for Startup) | Seed |
| C&Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
$110K grant received from Startup SG.
Stemden Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stemden's valuation, stock price, and market status.